Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer

Summary

Participation Requirements

Description

Patients will first go through an inclusion check-up consisting of: a clinical exam: disease history, previous treatments, weight, height, patient's performance status (ECOG) and HCC status. a biological test: biochemical (total bilirubin, ASAT-ALAT, LDH, albumin, alkaline phosphatases, GGT), hemato...

Patients will first go through an inclusion check-up consisting of: a clinical exam: disease history, previous treatments, weight, height, patient's performance status (ECOG) and HCC status. a biological test: biochemical (total bilirubin, ASAT-ALAT, LDH, albumin, alkaline phosphatases, GGT), hematological (if the patient is going to receive a fiducial), alphafoetoprotein (for HCC) and pregnancy test (if applicable) a tumor assessment: using a CT-scan or a MRI and using RECIST or mRECIST (if HCC), plus other morphological exams if judged useful by the investigator This check-up has to be realized within 28 days before inclusion. Then, the use of fiducial is optional. Before the beginning of the treatment, a pre-therapeutic check-up is done: the inclusion check-up has to be done a second time if the treatment begins more than 28 days after the first one Tracking scanner. The SBRT treatment is done in 3 to 6 times and no specific SBRT techniques are asked for, the investigator can choose according to the center habits. After the treatment, a follow-up will be realized at 3, 6, 9, 12, 18, 24, 30 and 36 months and then once a year until the last patient included reach their 36th month of follow-up. The follow-up check-up consists of a clinical exam, biological test, tumor assessment and tolerance assessment.

Tracking Information